Genomics

Dataset Information

0

RNA Editing in breast cancer

ABSTRACT: High-throughput sequencing screens suggest that RNA editing, which consists in the substitution of adenosine with inosine by the RNA-specific adenosine deaminase (ADAR) enzyme, occurs at several thousand positions across the human genome. Recent evidences have shown that RNA-editing could promote proliferation and carcinogenesis; however, the general principles of ADAR activity on the transcriptome and how ADAR is controlled in cancers remain to be established. The main aim of this project was to investigate the phenomenon of RNA editing in breast and other cancers. The frequency of A-to-I editing was evaluated in 58 breast cancers equally distributed among the different molecular subtypes and 10 normal breast tissues. The analysis was focused on defining: the relationship between the global amount of editing and ADAR expression; the ability to predict the level of editability of specific sites; the distribution of editing in normal and tumour samples and among different breast cancer subtypes; and the clinical, pathological and genomic factors affecting editing.

PROVIDER: EGAS00001000495 | EGA |

REPOSITORIES: EGA

Json Xml
altmetric image

Publications

<h4>Background</h4>Microarrays have revolutionized breast cancer (BC) research by enabling studies of gene expression on a transcriptome-wide scale. Recently, RNA-Sequencing (RNA-Seq) has emerged as an alternative for precise readouts of the transcriptome. To date, no study has compared the ability of the two technologies to quantify clinically relevant individual genes and microarray-derived gene expression signatures (GES) in a set of BC samples encompassing the known molecular BC's subtypes.  ...[more]

Similar Datasets

Transcriptomics The dsRBP and inactive editor, ADR-1, utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome
2014-01-20 | E-GEOD-51556 | biostudies-arrayexpress
Transcriptomics The dsRBP and inactive editor, ADR-1, utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome
2014-01-20 | GSE51556 | GEO
Genomics RNA Editing in breast cancer
| PRJEB4915 | ENA
Transcriptomics Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing
2010-07-29 | E-GEOD-19719 | biostudies-arrayexpress
Other Programmable RNA base editing with a single engineered protein
2022-09-20 | GSE155734 | GEO
Proteomics,Multiomics Genome-wide identification and functional analysis of Apobec-1 mediated C-to-U RNA editing in mouse small intestine and liver
2014-06-02 | PXD001007 | Pride
Transcriptomics Characterizing gene expression changes that accompany succinate dehydrogenase subunit B (SDHB) RNA editing in monocyte-enriched peripheral blood mononuclear cell cultures
2013-04-10 | E-GEOD-45900 | biostudies-arrayexpress
Transcriptomics Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA editing targets in transcript 3'UTRs
2011-01-23 | GSE24958 | GEO
Genomics Programmed RNA Editing with an Evolved Bacterial Adenosine Deaminase
| PRJNA1055593 | ENA
Transcriptomics ADAR1 RNA editing quenches innate immune activation in endothelial cells
2021-12-27 | GSE174216 | GEO